CTOs on the Move

Essilor

www.essilor.com

 
The world`s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant®, Bolon™ and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals. Essilor reported consolidated revenue of more than €7.1 billion in 2016 and employs 64,000 people worldwide. ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $250-500 Million
  • www.essilor.com
  • 501 Merritt Avenue
    Nashville, TN USA 37203
  • Phone: 615.256.6631

Executives

Name Title Contact Details

Similar Companies

RFTechnologies

RFTechnologies is a Brookfield, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ELM Communications

ELM Communications is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Injex-Equidyne Systems

Injex-Equidyne Systems is a Fullerton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Perseon Corporation

Perseon Corporation invests its resources in fighting humanity`s worst disease: cancer. Perseon`s people are dedicated to finding innovative technologies and means to deliver energy solutions to healthcare providers and patients around the world. MicroThermX® treats soft tissue tumors with precision-focused energy, expanding the options and broadening the opportunities for cancer treatment.

Avation Medical

Avation Medical is an innovative advanced neuromodulation and digital health company pioneering closed-loop, patient-friendly, wearable neuromodulation therapies that deliver personalized therapy based on the patient`s own physiologic response. The Company`s intelligent wearable therapies objectively confirm activation of the target nerve and make neuromodulation technology accessible to millions of patients across a variety of clinical application by eliminating need for surgery, needles and permanent implants and shifting therapy into the home environment.